CFDE Workbench
DataKnowledgeCloudtrainingcoordination
CFDE Workbench

COL Q92484-1 GLY 000329 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)
Protein:

ASM3A HUMAN

Protein (Entity type)
Project:

Portal

Project (Entity type)
Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)
Dcc:

GlyGen

DCC (Entity type)
Collection:

human proteoform glycosylation sites glyconnect.csv

File (Entity type)
Description:Information for protein Q92484-1 in the context of file GLY_000329
Creation Time:2026-03-02 19:56:31.000000
Results found

Linked to

 

Label

Description

 

Anatomy

blood serum

Anatomy (Entity type)

The portion of blood plasma that excludes clotting factors.

Anatomy

mammary gland

Anatomy (Entity type)

A specialized accessory gland of the skin of mammals that secretes milk. The gland is typically only...

Compound

G74724QE

Compound (Entity type)

type="BaseComposition" mass="1056.38568928" permass="1322.68304061" monosaccharides="6" is_motif="Fa...

Compound

G82463GQ

Compound (Entity type)

type="Composition" mass="1728.60821665" permass="2163.09336882" monosaccharides="9" is_motif="False"...

Compound

G51640FO

Compound (Entity type)

type="BaseComposition" mass="2030.7560032" permass="2507.28810558" monosaccharides="11" is_motif="Fa...

Protein

ASM3A HUMAN

Protein (Entity type)

Cyclic GMP-AMP phosphodiesterase SMPDL3A (precursor)

Post Translational Modification

q92484-1 356asn 356asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q92484-1 263asn 263asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

  • Anatomy

    blood serum

    Anatomy (Entity type)

    The portion of blood plasma that excludes clotting factors.

  • Anatomy

    mammary gland

    Anatomy (Entity type)

    A specialized accessory gland of the skin of mammals that secretes milk. The gland is typically only...

  • Compound

    G74724QE

    Compound (Entity type)

    type="BaseComposition" mass="1056.38568928" permass="1322.68304061" monosaccharides="6" is_motif="Fa...

  • Compound

    G82463GQ

    Compound (Entity type)

    type="Composition" mass="1728.60821665" permass="2163.09336882" monosaccharides="9" is_motif="False"...

  • Compound

    G51640FO

    Compound (Entity type)

    type="BaseComposition" mass="2030.7560032" permass="2507.28810558" monosaccharides="11" is_motif="Fa...

  • Protein

    ASM3A HUMAN

    Protein (Entity type)

    Cyclic GMP-AMP phosphodiesterase SMPDL3A (precursor)

  • Post Translational Modification

    q92484-1 356asn 356asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    q92484-1 263asn 263asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2026
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2026
    This repository is under review for potential modification in compliance with Administration directives.